Medica 2019: A complete success

Dusseldorf. After this year’s Medica, Stapleline has drawn a positive balance. From 18 to 21 November, the team was able to prove itself at the world’s largest medical trade fair and explain the company’s new course. Visitors were able to see for themselves on Tuesday, November 19, at the presentation by Natalia Krychtina (CEO) and Olaf Herrmann (CTO). Under the motto “Connecting quality; how Stapleline understands and offers quality”, the duo presented the new principles and goals of the company at the joint NRW stand. An important topic of the lecture was the priority of Stapleline – to make the maximum contribution to the well-being of the patients. The company from Bochum, Germany wants to expand their German quality further into the international market and is pleased about every new distributor from the not yet marketed countries.

With more than 5,500 exhibitors from 71 nations, the team used Medica with great success.

Interested parties from all over the world visited Stapleline in Hall 3 and exchanged ideas about products and strategies over a delicious cup of coffee. Already existing partners, like MegaMed from Russia, took the opportunity to meet again and have a little chat in person.

The team was honoured by the visit of the Japanese delegation, which, in regard of the NRW – Japan Seminar, is particularly committed to the cooperation of German companies from NRW with Japan. Following Medica, Medical Creation Fukushima 2019 also took place a week later in – the trade fair for medical technology in Japan, where Stapleline continued its fair appearance, but more about that later.

With the end of Medica 2019 Mrs. Krychtina is happy about a very exciting and profitable week and thanks all the visitors of the Stapleline booth for the successful days!

Weitere Beiträge

Japan Reise Stapleline

Medical Technology NRW-Japan

After the Japanese delegation had visited Stapleline at Medica 2019, the team flew to Fukushima, Japan, accompanied by several North Rhine-Westphalian medical technology companies, one

Weiterlesen »